Literature DB >> 10794129

Taurine release modified by GABAergic agents in hippocampal slices from adult and developing mice.

P Saransaari1, S S Oja.   

Abstract

In order to characterize the possible regulation of taurine release by GABAergic terminals, the effects of several agonists and antagonists of GABA receptors on the basal and K+-stimulated release of [3H]taurine were investigated in hippocampal slices from adult (3-month-old) and developing (7-day-old) mice using a superfusion system. Taurine release was concentration-dependently potentiated by GABA, which effect was reduced by phaclofen, saclofen and (1,2,5,6-tetrahydropyridin-4-yl)methylphosphinic acid (TPMPA) at both ages, suggesting regulation by both GABA(B) and GABA(C) receptors. The involvement of GABA(A) receptors could not be excluded since the antagonist bicuculline was able to affect both basal and K+-evoked taurine release. Furthermore, several GABA(B) receptor effectors were able to inhibit K+-stimulated taurine release in the adults, while the GABA(C) receptor agonists trans-4-aminocrotonic acid (TACA) and cis-4-aminocrotonic acid (CACA) potentiated this release. The potentiation of taurine release by agents acting on the three types of GABA receptors in both adult and developing hippocampus further indicates the involvement of transporters operating in an outward direction. This inference is corroborated by the moderate but significant inhibition of taurine uptake by the same compounds.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10794129     DOI: 10.1007/s007260050002

Source DB:  PubMed          Journal:  Amino Acids        ISSN: 0939-4451            Impact factor:   3.520


  2 in total

1.  Carrier-mediated uptake and release of taurine from Bergmann glia in rat cerebellar slices.

Authors:  L Barakat; D Wang; A Bordey
Journal:  J Physiol       Date:  2002-06-15       Impact factor: 5.182

2.  An Update on GABAρ Receptors.

Authors:  Gustavo Martínez-Delgado; Argel Estrada-Mondragón; Ricardo Miledi; Ataúlfo Martínez-Torres
Journal:  Curr Neuropharmacol       Date:  2010-12       Impact factor: 7.363

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.